Company Overview and News

 
Global Focus & Industry Leadership: Third China International Silver Industry Exhibition Held in Guangzhou

2016-11-20 prnewswire
GUANGZHOU, China, Nov. 18, 2016 /PRNewswire/ -- On November 13 2016, the third China International Silver Industry Exhibition concluded at the Guangzhou Poly World Trade Center. The exhibition was held over an area of 22,000sqm, with over 300 globally recognized senior care brands and enterprises in participation to welcome 32,916 visitors. On the successful foundations of previous two exhibitions, the third China International Silver Industry Exhibition continued to demonstrate leadership within the industry by facilitating in-depth integration of the advantageous resources of government, industry, and channels while bringing together globally leading silver industry products, technologies, and trends.

 
Yuexiu Property acquires Hangzhou land for about $200 mil

2016-07-11 theedgemarkets
SINGAPORE (July 11): Yuexiu Property has acquired a parcel of land in Niu Tian, Jianggan District, Hangzhou City in the Zhejiang Province of China for a consideration sum of RMB 986 million ($200 million).

 
Advancer Global, Yuexiu Property, Asiaphos, Swiber

2016-07-11 theedgemarkets
Advancer Global, the manpower solutions and facilities management provider, starts trading on the Catalist board on Monday. The group sold 43 million new shares at 22 cents each to raise $7.5 million in net proceeds. It intends to use $6.4 million to expand its business in to complementary services and overseas markets.

 
Mainland China developer Yuexiu Property sees net profit fall 59 per cent

2016-02-29 scmp
Guangdong-based company takes a hit from yuan devaluation

 
Hong Kong-listed Yuexiu Property to delist shares traded in Singapore

2016-01-20 businesstimes.com.sg
HONG Kong-listed Yuexiu Property Company Limited said on Wednesday that it has proposed to delist the shares that are currently traded on the Singapore Exchange (SGX) on a secondary listing. Read more at The Business Times.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

8h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

8h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

18h - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...